Omega-3 Supplement Has No Effect on Alzheimer's Patients

The Physicians Committee

Omega-3 Supplement Has No Effect on Alzheimer's Patients

November 4, 2010

Omega-3 supplements do not slow mental decline in Alzheimer’s patients, according to a new study published in the Journal of the American Medical Association. In this trial conducted by the Alzheimer’s Disease Cooperative Study, Alzheimer’s patients who took an omega-3 supplement showed no benefit in cognition or brain atrophy. Researchers randomly assigned 402 participants to either a docosahexaenoic acid (DHA) supplement (2 grams per day) or a placebo for 18 months. Fish oil and other fish products are often touted for their omega-3 fatty acid—specifically DHA—content.

Quinn JF, Rama R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease. JAMA. 2010;304:1903-1911.

Subscribe to the Physicians Committee's Breaking Medical News.

Breaking Medical News is a service of the Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., Ste. 400, Washington, DC 20016, 202-686-2210. Join the Physicians Committee and receive the quarterly magazine, Good Medicine.

Breaking Medical News Archive:
2016 (80)
2015 (80)
2014 (71)
2013 (67)
2012 (34)
2011 (16)
2010 (36)
2009 (27)
2008 (21)
2007 (18)
2006 (21)
2005 (13)
2004 (9)
2003 (11)
2002 (9)


Meet PCRM's Nutrition Experts